See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

DHTV
Popular
Top Rated

Related Medications Videos on Diabetes Health TV

Could Byetta Become a Standalone Drug?

Craig Eberhard

Could Byetta Become a Standalone Drug?

Dr. Sheri Colberg Interviewed by Scott King

Dr. Sheri Colberg

Dr. Sheri Colberg Interviewed by Scott King

Diabetes Medication

Updated 4 weeks ago
BI-Lilly Alliance Creates Formidable Drug Development Combine
Jul 17, 2014 | 
Pharma giants Boehringer Ingelheim (BI) and Eli Lilly and Company (Lilly) have formed the
FDA Approves New Neuropathy Pain Drug
Sep 11, 2012 | 
The US Food and Drug Administration has approved US sales of NUCYNTA® ER (tapentadol), a twice-daily extended-release oral analgesic for the treatment of pain from diabetic peripheral neuropathy. The drug, produced by New Jersey-based Janssen Pharmaceuticals, Inc., provides around-the-clock management for moderate to severe chronic neuropathic pain. Janssen says that it is currently the only opioid on the US market that has been approved for treating the condition.
DHTV
Popular
Top Rated

Related Medications Videos on Diabetes Health TV

Could Byetta Become a Standalone Drug?

Craig Eberhard

Could Byetta Become a Standalone Drug?

Dr. Sheri Colberg Interviewed by Scott King

Dr. Sheri Colberg

Dr. Sheri Colberg Interviewed by Scott King

The i-port®

Davida Kruger and KK Patton

The i-port®


Fatal error: Call to a member function getUrl() on a non-object in /home/diabetes/public_html/browse.php on line 54